Kwang Dong Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in South Korean won today
Kwang Dong Pharmaceutical Co., Ltd. revenue for the past few reporting periods. Kwang Dong Pharmaceutical Co., Ltd. net revenue for today is 294 141 705 980 ₩. Net income, revenue and dynamics - the main financial indicators of Kwang Dong Pharmaceutical Co., Ltd.. The financial graph of Kwang Dong Pharmaceutical Co., Ltd. shows the values and changes of such indicators: total assets, net income, net revenue. Kwang Dong Pharmaceutical Co., Ltd. financial report on the graph shows the dynamics of assets. Information on Kwang Dong Pharmaceutical Co., Ltd. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Kwang Dong Pharmaceutical Co., Ltd. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Kwang Dong Pharmaceutical Co., Ltd. is 31/03/2021. Gross profit Kwang Dong Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Kwang Dong Pharmaceutical Co., Ltd. is 60 781 068 540 ₩
Cost of revenue Kwang Dong Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Kwang Dong Pharmaceutical Co., Ltd. is 233 360 637 440 ₩ Total revenue Kwang Dong Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Kwang Dong Pharmaceutical Co., Ltd. is 294 141 705 980 ₩ Operating income Kwang Dong Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Kwang Dong Pharmaceutical Co., Ltd. is 8 510 882 290 ₩
Net income Kwang Dong Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Kwang Dong Pharmaceutical Co., Ltd. is 6 152 986 400 ₩ Current assets Kwang Dong Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Kwang Dong Pharmaceutical Co., Ltd. is 567 641 176 170 ₩ Total assets Kwang Dong Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Kwang Dong Pharmaceutical Co., Ltd. is 827 583 792 700 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
60 781 068 540 ₩
60 255 115 520 ₩
66 706 054 800 ₩
68 516 108 750 ₩
65 460 451 420 ₩
67 796 635 510 ₩
60 200 422 000 ₩
56 925 120 410 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
233 360 637 440 ₩
244 388 621 400 ₩
249 166 628 340 ₩
254 065 722 340 ₩
238 087 983 000 ₩
255 684 469 720 ₩
233 762 834 480 ₩
237 749 411 310 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
294 141 705 980 ₩
304 643 736 920 ₩
315 872 683 140 ₩
322 581 831 090 ₩
303 548 434 420 ₩
323 481 105 230 ₩
293 963 256 480 ₩
294 674 531 720 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
303 548 434 420 ₩
323 481 105 230 ₩
293 963 256 480 ₩
294 674 531 720 ₩
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
8 510 882 290 ₩
8 418 588 110 ₩
13 496 040 580 ₩
13 671 896 560 ₩
8 548 756 430 ₩
14 175 429 160 ₩
12 387 172 560 ₩
6 761 329 370 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
6 152 986 400 ₩
-6 790 091 030 ₩
30 515 252 590 ₩
10 961 497 930 ₩
4 097 185 020 ₩
7 385 280 480 ₩
9 114 710 940 ₩
1 706 575 800 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 256 592 000 ₩
1 259 237 000 ₩
1 491 200 000 ₩
1 848 040 000 ₩
1 617 626 000 ₩
1 181 799 000 ₩
1 533 333 000 ₩
1 633 975 000 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
285 630 823 690 ₩
296 225 148 810 ₩
302 376 642 560 ₩
308 909 934 530 ₩
294 999 677 990 ₩
309 305 676 070 ₩
281 576 083 920 ₩
287 913 202 350 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
567 641 176 170 ₩
584 494 494 750 ₩
564 549 383 150 ₩
543 131 291 000 ₩
473 337 790 910 ₩
476 086 513 040 ₩
478 181 373 000 ₩
459 081 837 910 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
827 583 792 700 ₩
830 643 378 840 ₩
826 694 465 660 ₩
802 671 134 800 ₩
762 044 890 450 ₩
764 299 034 970 ₩
755 276 580 000 ₩
732 056 804 260 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
55 314 724 390 ₩
54 881 526 250 ₩
64 296 081 470 ₩
86 502 295 720 ₩
70 947 447 370 ₩
50 624 467 710 ₩
51 530 369 000 ₩
67 482 593 970 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
272 182 343 850 ₩
277 918 609 270 ₩
275 512 547 000 ₩
271 353 254 040 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
316 202 404 920 ₩
322 791 900 250 ₩
321 784 533 000 ₩
301 218 199 950 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
41.49 %
42.23 %
42.60 %
41.15 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
480 618 536 880 ₩
477 661 331 350 ₩
485 715 359 690 ₩
449 540 740 020 ₩
419 982 757 780 ₩
416 337 504 640 ₩
407 605 390 000 ₩
405 319 720 690 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
22 002 024 250 ₩
-5 292 144 830 ₩
-7 895 789 000 ₩
23 579 332 400 ₩
Last revenue report of Kwang Dong Pharmaceutical Co., Ltd. was 31/03/2021. According to last financial report total revenue in Kwang Dong Pharmaceutical Co., Ltd. was 294 141 705 980 South Korean won and changed by +0.0607% since last year. Net income in Kwang Dong Pharmaceutical Co., Ltd. was 6 152 986 400 ₩ in last quartal, net income changes to -32.494%.
Current cash Kwang Dong Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Kwang Dong Pharmaceutical Co., Ltd. is 55 314 724 390 ₩
